Chitosan as a Vaccine Adjuvant: From Material Determinants to Innate Immune Activation and Formulation Optimization

Area of Science:

• Biomaterials Science
• Immunology
• Vaccine Development

Background:

• Chitosan is a chemically tunable material with potential as a vaccine adjuvant.
• Understanding its material properties and immune activation pathways is crucial for effective vaccine design.

Purpose of the Study:

• To review the current understanding of chitosan as a vaccine adjuvant.
• To connect material determinants with innate immune activation and formulation design.
• To identify translational challenges and provide a framework for rational selection of chitosan-based adjuvant platforms.

Main Methods:

• Materials science perspective on chitosan properties (molecular weight, charge density, composites).
• Immunological perspective on chitosan-mediated innate immune activation pathways (e.g., cGAS-STING, NLRP3 inflammasome, TLRs).
• Analysis of chitosan formulations (nanoparticles, hydrogels) and synergistic adjuvant systems.

Main Results:

• Chitosan's physicochemical properties influence its adjuvant activity.
• Chitosan activates innate immunity through multiple pathways, balancing humoral and cellular responses.
• Various formulations and synergistic combinations show promise for vaccine development.

Conclusions:

• Rational formulation selection and standardization of critical quality attributes are essential for chitosan-based adjuvants.
• Addressing translational challenges like solubility and reproducibility is key for clinical feasibility.
• This review provides a theoretical framework for advancing chitosan adjuvant technology.